GLAXO SMITH KLINE
- Novartis buys remaining rights to GSK treatment in deal up to $1 billion ClusterStock
- In Puzzling Move, Novartis AG Offers $1 Billion for GlaxoSmithKline???s Ofatumumab for Auto-Immune D Bio Space - All News
- GSK recalls 3.9M tubes of toothpaste that may have wood fragments in them Fierce Pharma Manufacturing
- GSK beefing up in U.S. drug and inhaler plant Fierce Pharma Manufacturing
- Toothpaste being recalled due to wood fragments WHP - CBS - Harrisburg, PA
- Pfizer Enters Into Agreement To Acquire Nimenrix And Mencevax From GlaxoSmithKline Business Wire Health News
- Avalon, GlaxoSmithKline launch 3 new biotechs with $30M commitment Fierce Biotech News
- Fresh off Novartis consumer deal, GSK slices off 350 workers to hit cost-squeezing targets Fierce Pharma
- Perrigo Buys GlaxoSmithKline, Novartis Consumer Medicines Fidelity - Merger and Acquision News
- GSK, UNC-Chapel Hill partner to accelerate search for HIV cure Outsourcing-Pharma - Breaking News
Community Payment Ratings
Cortera is much more than an awesome business directory! It's an active community where real business people share the real deal on real businesses.
It's invaluable intel that's now available for FREE.
- Get the inside scoop with ratings and reviews on GLAXO SMITH KLINE
- Rate GLAXO SMITH KLINE on their payment behavior
- Ask your network about GLAXO SMITH KLINE with Cortera Circles
The information contained in this company profile is compiled from third party sources, including but not limited to public records, user submissions, and other commercially available data sources. These sources may not be accurate, complete, or up-to-date. Cortera makes no representations or warranties regarding, and assumes no responsibility for, the accuracy, completeness, or currency of the information contained herein.